Hong Kong Stock Market Anomaly | Lai Kai Medicine-B (02105.HK) morning rose nearly 15% in the morning, new progress has been made in the exclusive licensing agreement of LAE118, and the first payment from Vasque Bio has been received.

Zhitong Finance and Economics APP learned that Lai Kai Pharmaceutical-B (02105.HK) rose nearly 15% in the morning session, as of the time of publication, it rose 14.63%, to 7.13 Hong Kong dollars, with a turnover of 9.0682 million Hong Kong dollars.